Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Healthcare Capital (SHC) is a leading investment firm based in Shanghai, China, dedicated to the life sciences and healthcare sectors. Managed by Shanghai Industrial Investment (Holdings) Co., Ltd. (SIIC) and backed by the Shanghai Municipal Government, the firm manages the Shanghai Biological Medicine Fund with a target size of RMB 50 billion. SHC focuses on the entire healthcare value chain, including innovative drug development, high-end medical devices, and medical services. The firm operates a specialized Angel Fund designed to support early-stage startups and facilitate the commercialization of academic research, playing a pivotal role in strengthening Shanghai's global position in the biomedical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Healthcare Capital.